Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3952 | 1875 | 42.8 | 82% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
316 | 3 | RHEUMATOLOGY//RHEUMATOID ARTHRITIS//RHEUMATOL | 39766 |
195 | 2 | RHEUMATOID ARTHRITIS//RHEUMATOLOGY//RHEUMATOL | 21443 |
3952 | 1 | RHEUMATOID ARTHRITIS//EPIDEMIOL COMPUTAT BIOL//EPIDEMIOL GENET ATHEROSCLEROSIS GRP SYST IN | 1875 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | RHEUMATOID ARTHRITIS | authKW | 447887 | 39% | 4% | 738 |
2 | EPIDEMIOL COMPUTAT BIOL | address | 378201 | 3% | 41% | 56 |
3 | EPIDEMIOL GENET ATHEROSCLEROSIS GRP SYST IN | address | 258040 | 1% | 59% | 27 |
4 | RHEUMATOLOGY | WoSSC | 234315 | 64% | 1% | 1198 |
5 | ANTI TNF ALPHA ANTIBODY INFLIXIMAB | authKW | 212773 | 1% | 93% | 14 |
6 | PREVENT CARDIORHEUMA CLIN | address | 195405 | 1% | 100% | 12 |
7 | RHEUMATOL | address | 195361 | 37% | 2% | 692 |
8 | CARDIOVASC PATHOPHYSIOL GENOM UNIT | address | 137759 | 2% | 26% | 32 |
9 | DUDLEY GRP HOSP NHS TRUST | address | 102283 | 1% | 37% | 17 |
10 | IFIMAV | address | 89742 | 2% | 15% | 36 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Rheumatology | 234315 | 64% | 1% | 1198 |
2 | Cardiac & Cardiovascular System | 1319 | 12% | 0% | 216 |
3 | Medicine, General & Internal | 669 | 10% | 0% | 192 |
4 | Peripheral Vascular Diseases | 554 | 6% | 0% | 108 |
5 | Medicine, Research & Experimental | 38 | 3% | 0% | 55 |
6 | Immunology | 29 | 4% | 0% | 73 |
7 | Medical Laboratory Technology | 5 | 1% | 0% | 10 |
8 | Primary Health Care | 2 | 0% | 0% | 4 |
9 | Pharmacology & Pharmacy | 0 | 3% | 0% | 61 |
10 | Orthopedics | -0 | 1% | 0% | 13 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EPIDEMIOL COMPUTAT BIOL | 378201 | 3% | 41% | 56 |
2 | EPIDEMIOL GENET ATHEROSCLEROSIS GRP SYST IN | 258040 | 1% | 59% | 27 |
3 | PREVENT CARDIORHEUMA CLIN | 195405 | 1% | 100% | 12 |
4 | RHEUMATOL | 195361 | 37% | 2% | 692 |
5 | CARDIOVASC PATHOPHYSIOL GENOM UNIT | 137759 | 2% | 26% | 32 |
6 | DUDLEY GRP HOSP NHS TRUST | 102283 | 1% | 37% | 17 |
7 | IFIMAV | 89742 | 2% | 15% | 36 |
8 | IIS PRINCESA | 74417 | 1% | 29% | 16 |
9 | CARDIOVASC ICAR | 43421 | 0% | 67% | 4 |
10 | IRCCS GALEAZZI ORTHOPED | 39074 | 0% | 40% | 6 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANNALS OF THE RHEUMATIC DISEASES | 53571 | 9% | 2% | 171 |
2 | JOURNAL OF RHEUMATOLOGY | 29860 | 8% | 1% | 153 |
3 | ARTHRITIS RESEARCH & THERAPY | 25801 | 4% | 2% | 72 |
4 | RHEUMATOLOGY | 19991 | 4% | 2% | 76 |
5 | CLINICAL RHEUMATOLOGY | 19968 | 4% | 2% | 81 |
6 | ARTHRITIS CARE & RESEARCH | 19028 | 2% | 3% | 45 |
7 | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 18892 | 4% | 1% | 80 |
8 | SEMINARS IN ARTHRITIS AND RHEUMATISM | 13929 | 2% | 2% | 41 |
9 | ARTHRITIS AND RHEUMATISM | 12761 | 5% | 1% | 90 |
10 | SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 12680 | 3% | 2% | 48 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | AGCA, R , HESLINGA, SC , ROLLEFSTAD, S , HESLINGA, M , MCINNES, B , PETERS, MJL , KVIEN, TK , DOUGADOS, M , RADNER, H , ATZENI, F , ET AL (2017) EULAR RECOMMENDATIONS FOR CARDIOVASCULAR DISEASE RISK MANAGEMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS AND OTHER FORMS OF INFLAMMATORY JOINT DISORDERS: 2015/2016 UPDATE.ANNALS OF THE RHEUMATIC DISEASES. VOL. 76. ISSUE 1. P. 17 -28 | 105 | 72% | 4 |
2 | PETERS, MJL , SYMMONS, DPM , MCCAREY, D , DIJKMANS, BAC , NICOLA, P , KVIEN, TK , MCINNES, IB , HAENTZSCHEL, H , GONZALEZ-GAY, MA , PROVAN, S , ET AL (2010) EULAR EVIDENCE-BASED RECOMMENDATIONS FOR CARDIOVASCULAR RISK MANAGEMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS AND OTHER FORMS OF INFLAMMATORY ARTHRITIS.ANNALS OF THE RHEUMATIC DISEASES. VOL. 69. ISSUE 2. P. 325-331 | 73 | 75% | 553 |
3 | CASTANEDA, S , NURMOHAMED, MT , GONZALEZ-GAY, MA , (2016) CARDIOVASCULAR DISEASE IN INFLAMMATORY RHEUMATIC DISEASES.BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY. VOL. 30. ISSUE 5. P. 851 -869 | 101 | 77% | 0 |
4 | SZEKANECZ, Z , KEREKES, G , VEGH, E , KARDOS, Z , BARATH, Z , TAMASI, L , SHOENFELD, Y , (2016) AUTOIMMUNE ATHEROSCLEROSIS IN 3D: HOW IT DEVELOPS, HOW TO DIAGNOSE AND WHAT TO DO.AUTOIMMUNITY REVIEWS. VOL. 15. ISSUE 7. P. 756 -769 | 112 | 63% | 1 |
5 | KAPLAN, MJ , (2010) CARDIOVASCULAR COMPLICATIONS OF RHEUMATOID ARTHRITIS: ASSESSMENT, PREVENTION, AND TREATMENT.RHEUMATIC DISEASE CLINICS OF NORTH AMERICA. VOL. 36. ISSUE 2. P. 405-+ | 109 | 74% | 24 |
6 | AMAYA-AMAYA, J , SARMIENTO-MONROY, JC , MANTILLA, RD , PINEDA-TAMAYO, R , ROJAS-VILLARRAGA, A , ANAYA, JM , (2013) NOVEL RISK FACTORS FOR CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS.IMMUNOLOGIC RESEARCH. VOL. 56. ISSUE 2-3. P. 267-286 | 107 | 71% | 9 |
7 | SHEN, JY , SHANG, Q , TAM, LS , (2016) TARGETING INFLAMMATION IN THE PREVENTION OF CARDIOVASCULAR DISEASE IN PATIENTS WITH INFLAMMATORY ARTHRITIS.TRANSLATIONAL RESEARCH. VOL. 167. ISSUE 1. P. 138 -151 | 104 | 70% | 0 |
8 | NURMOHAMED, MT , HESLINGA, M , KITAS, GD , (2015) CARDIOVASCULAR COMORBIDITY IN RHEUMATIC DISEASES.NATURE REVIEWS RHEUMATOLOGY. VOL. 11. ISSUE 12. P. 693 -704 | 80 | 59% | 23 |
9 | SEN, D , GONZALEZ-MAYDA, M , BRASINGTON, RD , (2014) CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS.RHEUMATIC DISEASE CLINICS OF NORTH AMERICA. VOL. 40. ISSUE 1. P. 27-+ | 88 | 65% | 6 |
10 | HOLLAN, I , DESSEIN, PH , RONDA, N , WASKO, MC , SVENUNGSSON, E , AGEWALL, S , COHEN-TERVAERT, JW , MAKI-PETAJA, K , GRUNDTVIG, M , KARPOUZAS, GA , ET AL (2015) PREVENTION OF CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS.AUTOIMMUNITY REVIEWS. VOL. 14. ISSUE 10. P. 952 -969 | 95 | 49% | 14 |
Classes with closest relation at Level 1 |